252 related articles for article (PubMed ID: 24983743)
1. Pulmonary embolism: current and new treatment options.
Walter RJ; Moores LK; Jiménez D
Curr Med Res Opin; 2014 Oct; 30(10):1975-89. PubMed ID: 24983743
[TBL] [Abstract][Full Text] [Related]
2. Effective diagnosis and treatment of pulmonary embolism: Improving patient outcomes.
Meyer G
Arch Cardiovasc Dis; 2014; 107(6-7):406-14. PubMed ID: 25023859
[TBL] [Abstract][Full Text] [Related]
3. Acute pulmonary embolism: risk assessment, risk stratification and treatment options.
Piovella F; Iosub DI
Clin Respir J; 2016 Sep; 10(5):545-54. PubMed ID: 25619266
[TBL] [Abstract][Full Text] [Related]
4. Managing pulmonary embolism from presentation to extended treatment.
Cohen AT; Dobromirski M; Gurwith MM
Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
[TBL] [Abstract][Full Text] [Related]
5. The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulants.
Hull RD; Gersh MH
Curr Med Res Opin; 2015 Feb; 31(2):197-210. PubMed ID: 25299352
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of pulmonary embolism.
Gouin B; Robert-Ebadi H; Righini M; Blondon M
Expert Opin Pharmacother; 2017 Jan; 18(1):79-93. PubMed ID: 27917690
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
Rollins BM; Silva MA; Donovan JL; Kanaan AO
Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
[TBL] [Abstract][Full Text] [Related]
8. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
9. Direct oral anticoagulants as alternative treatment options for the effective long-term treatment of patients with pulmonary embolism in primary care: a review.
Toth PP
Ann Med; 2014 Sep; 46(6):341-52. PubMed ID: 24888386
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism management: where do novel anticoagulants fit?
Spyropoulos AC; Turpie AG
Curr Med Res Opin; 2013 Jul; 29(7):783-90. PubMed ID: 23659584
[TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants in the treatment of pulmonary embolism.
Eldredge JB; Spyropoulos AC
Curr Med Res Opin; 2018 Jan; 34(1):131-140. PubMed ID: 28771049
[TBL] [Abstract][Full Text] [Related]
12. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
Hillis C; Crowther MA
Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
[TBL] [Abstract][Full Text] [Related]
13. Long-term benefits of preventing venous thromboembolic events.
Cohen AT
Curr Med Res Opin; 2012 Jun; 28(6):877-89. PubMed ID: 22533680
[TBL] [Abstract][Full Text] [Related]
14. The potential of target-specific oral anticoagulants for the acute and long-term treatment of venous thromboembolism.
Akwaa F; Spyropoulos AC
Curr Med Res Opin; 2014 Nov; 30(11):2179-90. PubMed ID: 25105309
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
16. New oral anticoagulants for the treatment of venous thromboembolism.
Agnelli G; Becattini C; Franco L
Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
[TBL] [Abstract][Full Text] [Related]
17. Critical Review and Update on the Treatment of Acute and Chronic Pulmonary Embolism.
Shapiro NL; Bhatt SH
J Pharm Pract; 2016 Feb; 29(1):35-45. PubMed ID: 26589472
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.
Prandoni P
Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390
[TBL] [Abstract][Full Text] [Related]
19. Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease.
Voukalis C; Lip GY; Shantsila E
Expert Opin Pharmacother; 2016 Oct; 17(15):2033-47. PubMed ID: 27667112
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
